Healthcare -
Biotechnology - NASDAQ - US
$ 2.02
3.06 %
$ 62.7 M
Market Cap
-1.03
P/E
IMRX - STOCK-BASED COMPENSATION
Stock-based Compensation IMRX - Immuneering Corporation
5.73 M
LAST VALUE
78.24%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR